What clinicians need to know about PCI, other revascularization techniques among women

Michael Walter | | Cardiovascular Business | Interventional Cardiology
older female patient and doctor

The Society for Cardiovascular Angiography & Interventions (SCAI) has shared a new expert consensus statement focused on myocardial revascularization among female patients.

The document, published in full in the Journal of the Society for Cardiovascular Angiography & Interventions (JSCAI),[1] was designed to highlight sex-specific considerations healthcare providers should keep in mind when making treatment decisions related to percutaneous coronary intervention (PCI) and other revascularization techniques.

“This consensus is an international collaborative effort that highlights the knowns, the gaps and ambiguities in evidence related to sex-specific revascularization,” lead author Alexandra Lansky, MD, a professor of medicine in the cardiology section at the Yale School of Medicine and a practicing cardiologist at Yale-New Haven Hospital, said in a prepared statement.

Lansky, who serves as the JSACI’s editor-in-chief, noted that these recommendations also emphasize specific areas “in need of additional evidence.”

A draft of the consensus statement was peer reviewed back in May 2021, undergoing updates as necessary. It was fully endorsed by the SCAI Publications Committee and Executive Committee as an official society guidance in December 2021.

“SCAI statements are primarily intended to help clinicians make decisions about treatment alternatives,” according to the document. “Clinicians also must consider the clinical presentation, setting, and preferences of individual patients to make judgements about the optimal approach.”

Read the full expert consensus statement in JSCAI here.

 

Reference:

1. Alexandra Lansky, Suzanne J. Baron, Cindy L. Grines, et al. SCAI Expert Consensus Statement on Sex-Specific Considerations in Myocardial Revascularization. JSCAI. Published Feb. 04, 2022. DOI:https://doi.org/10.1016/j.jscai.2021.100016.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Q&A: Cardiologist and EARLY TAVR co-author questions study’s execution
AMA to advocate for improved Medicare payments for office-based labs
Balloon-expandable, self-expanding TAVR valves associated with comparable long-term outcomes
FastWave Medical reports first-in-human coronary laser IVL procedures
Study finds 35 million patients may be eligible for renal denervation
TAVR specialists come together to explore new data, patient selection and much more

Around the web

Health Exec
Tom Price: Medical residency slots need to expand to combat physician shortages

Tom Price, MD, former secretary of Health and Human Services (HHS), said one way to address the growing shortage of physicians is to expand medical resident positions, but these are tied to Medicare spending so alternative means may be needed.

Health Imaging
Tariffs will have a significant impact on the nuclear imaging supply chain in the US

"Domestic radiopharmaceutical suppliers, who receive isotopes from abroad, would be impacted by price changes and uncertainty caused by additional tariffs,” SNMMI President Cathy Cutler, PhD, wrote in a letter to the U.S. Department of Commerce this week.

Radiology Business
U.S. iodine contrast supply may not be subject to proposed 25% tariffs

If President Trump initiates a 25% tariff against pharmaceuticals imported from Ireland, it might impact the price for X-ray iodine contrast agents in the U.S. depending what rules are put in place.